Breaking News

Lonza Establishes Center of Excellence in Oregon

Can now provide capsule-based DPI formulations for feasibility studies in as little as 12 weeks.

By: Contract Pharma

Contract Pharma Staff

Lonza Pharma & Biotech has established a Center of Excellence for Dry Powder Inhaler (DPI) drug product development at its Bend, Oregon site. The DPI service offer leverages the particle engineering expertise and capabilities at Lonza-Bend while incorporating Lonza site network capabilities where applicable for specific customers and/or drug programs. The core service offer is comprised of a head-to-head evaluation of particle engineering approaches (spray drying and micronization), along wi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters